NCT07374679 Long-Term Follow-up Study to Evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients With Rotator Cuff Disease
| NCT ID | NCT07374679 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Rotator Cuff Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 21 participants |
| Start Date | 2026-01-27 |
| Primary Completion | 2031-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 21 participants in total. It began in 2026-01-27 with a primary completion date of 2031-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients with Rotator Cuff Disease
Eligibility Criteria
Inclusion Criteria: * Subjects who received the investigational medicinal product in the Phase 1/2a clinical trial (ASB-IP-001). * Subjects who voluntarily agreed to participate in this long-term follow-up study and provided written informed consent. Exclusion Criteria: * Subjects who cannot be contacted by any means, including telephone, mail, or e-mail, and for whom follow-up assessment is therefore not feasible. * Subjects deemed inappropriate for participation in this long-term follow-up study at the investigator's discretion, including: * Cases in which participation in the study may pose a significant risk to the subject's health or safety; ② Cases in which long-term follow-up visits or assessments are practically impossible due to cognitive impairment, communication difficulties, or similar conditions; ③ Cases in which continued participation in follow-up is unlikely due to difficulty adhering to the study schedule (e.g., prolonged hospitalization, long-term residence abroad).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07374679 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Rotator Cuff Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07374679 currently recruiting?
Yes, NCT07374679 is actively recruiting participants. Contact the research team at grant903@gmail.com for enrollment information.
Where is the NCT07374679 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT07374679 clinical trial?
NCT07374679 is sponsored by Seoul National University Hospital. The trial plans to enroll 21 participants.